Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. (American journal of pathology, 2002)

(untitled) - Grant, A; Goddard, S; Ahmed-Choudhury, J; Reynolds, G; Jackson, D; Briskin, M; Wu, L; Hübscher, S; Adams, D